Literature DB >> 10502511

Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins.

T Heiskanen1, A Lundkvist, R Soliymani, E Koivunen, A Vaheri, H Lankinen.   

Abstract

We selected peptide ligands mimicking the surface structure of discontinuous binding sites of Puumala hantavirus-neutralizing monoclonal antibodies from a random 18-amino acid peptide library containing a disulfide bridge in a fixed position and displayed on a filamentous phage. The varying of selection conditions, either by shortening of the association time or by competitive elution with antigen, was crucial for the selection of peptide inserts that could be aligned with the primary sequences of the envelope glycoproteins G1 and G2. Correspondingly, when the envelope glycoprotein sequences were synthesized as overlapping peptides as spots on membrane, the same site in primary structure was found as with phage display, which corroborates the use of the two methods in mapping of conformational epitopes. Also, epitopes reactive with early-phase sera from Puumala virus infection were defined with the pepspot assay in the amino-terminal region of G1. Similarities of the selected phage clones to a monoclonal antibody-escape mutant site and to a linear early-phase epitope were found. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10502511     DOI: 10.1006/viro.1999.9930

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Heteroduplex mobility assay (HMA) pre-screening: an improved strategy for the rapid identification of inserts selected from phage-displayed peptide libraries.

Authors:  F Fack; S Deroo; S Kreis; C P Muller
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

Review 2.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

3.  Interactions and oligomerization of hantavirus glycoproteins.

Authors:  Jussi Hepojoki; Tomas Strandin; Antti Vaheri; Hilkka Lankinen
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

4.  Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.

Authors:  Gregory P Owens; Andrew J Shearer; Xiaoli Yu; Alanna M Ritchie; Kathryne M Keays; Jeffrey L Bennett; Donald H Gilden; Mark P Burgoon
Journal:  J Virol       Date:  2006-12       Impact factor: 5.103

5.  Identification of measles virus epitopes using an ultra-fast method of panning phage-displayed random peptide libraries.

Authors:  Xiaoli Yu; Olga Barmina; Mark Burgoon; Don Gilden
Journal:  J Virol Methods       Date:  2009-01-03       Impact factor: 2.014

6.  Constraints on the conformation of the cytoplasmic face of dark-adapted and light-excited rhodopsin inferred from antirhodopsin antibody imprints.

Authors:  Brian W Bailey; Brendan Mumey; Paul A Hargrave; Anatol Arendt; Oliver P Ernst; Klaus Peter Hofmann; Patrik R Callis; James B Burritt; Algirdas J Jesaitis; Edward A Dratz
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

7.  Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein.

Authors:  Albert A Rizvanov; Albert G M van Geelen; Sergey Morzunov; Elmer W Otteson; Charlotte Bohlman; Gregory S Pari; Stephen C St Jeor
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

8.  Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection.

Authors:  Taylor B Engdahl; Natalia A Kuzmina; Adam J Ronk; Chad E Mire; Matthew A Hyde; Nurgun Kose; Matthew D Josleyn; Rachel E Sutton; Apoorva Mehta; Rachael M Wolters; Nicole M Lloyd; Francisca R Valdivieso; Thomas G Ksiazek; Jay W Hooper; Alexander Bukreyev; James E Crowe
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

9.  Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Authors:  Nicole Haese; Rebecca L Brocato; Thomas Henderson; Matthew L Nilles; Steve A Kwilas; Matthew D Josleyn; Christopher D Hammerbeck; James Schiltz; Michael Royals; John Ballantyne; Jay W Hooper; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

10.  A Molecular-Level Account of the Antigenic Hantaviral Surface.

Authors:  Sai Li; Ilona Rissanen; Antra Zeltina; Jussi Hepojoki; Jayna Raghwani; Karl Harlos; Oliver G Pybus; Juha T Huiskonen; Thomas A Bowden
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.